ArticleOncoimmunology2026

Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platform.

Tithi Ghosh Halder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.